MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0130223
Gromax Therapeutics Private Limited
Gromax Therapeutics Private Limited - consumer electronics & durables in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹9.31 Cr
▲ 27541% YoY
Net profit · FY 2022
₹2.5 Lakh
Net margin 0.3%
EBITDA · FY 2022
₹79,180
EBITDA margin 0.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹13.8 Cr
Secured borrowings
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
About Gromax Therapeutics Private Limited
Data last updated:
Gromax Therapeutics Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the electronics retail and distribution segment of the consumer electronics and durables sector. It was incorporated on 15 May 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U47211MH2018PTC309426. Its GSTIN is 10AAHCG3202G1ZE (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Aman Chirania and Satanand Vaibhaw.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at B – 205/206 Dhanashree Heights Next To Axis Bank Veeradesai Road Andheri (West) Mumbai, Maharashtra, India – 400053.
As per the financials filed for FY 2022, the company reported a revenue of ₹9.31 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹2.5 Lakh (net margin 0.3%) and EBITDA of ₹79,180 (EBITDA margin 0.1%). Revenue has grown at a compounded annual rate (CAGR) of 551% over three years.
As per MCA filings, the company has open charges of ₹13.8 Cr on record.
Gromax Therapeutics Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0130223).
Company details
CIN U47211MH2018PTC309426
Registration Number 309426
Incorporation Date 15 May 2018
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Small
Udyam Registration UDYAM-MH-19-0130223
CIN history
Gromax Therapeutics has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U47211MH2018PTC309426, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U47211MH2018PTC309426 | Current |
| U85320MH2018PTC309426 | Previous |
| U51100MH2018PTC309426 | Previous |
Key People
Aman Chirania Director Satanand Vaibhaw Director Recognitions & Rankings of Gromax Therapeutics
Contact details
Gromax Therapeutics Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressB – 205/206 Dhanashree Heights Next To Axis Bank Veeradesai Road Andheri (West) Mumbai, Maharashtra, India – 400053
- IndustryConsumer Electronics & Durables, Electronic Appliances Retail & Distribution
Comprehensive company report
Gromax Therapeutics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Gromax Therapeutics Private Limited
FY 2024 filings availableGromax Therapeutics Private Limited reported revenue of ₹9.31 Cr (up 27541% YoY) for FY 2022.
Revenue · FY 2022
₹9.31 Cr ▲ 27541%
Net profit · FY 2022
₹2.5 Lakh margin 0.3%
EBITDA · FY 2022
₹79,180 margin 0.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▲ 551%
EBITDA CAGR growth
1 year
▲ 11%
Revenue has grown at a compounded annual rate (CAGR) of 551% over three years. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ₹9.31 Cr | |||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹79,180 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹2.5 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 0.1% | |||
| Net Profit Margin | 0.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Gromax Therapeutics Private Limited, buy the company report.
Board of directors of Gromax Therapeutics Private Limited
Gromax Therapeutics has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aman Chirania | Director | 15 May 2018 | 8 Years 5 Months | Current |
| Satanand Vaibhaw | Director | 31 Mar 2021 | 5 Years 7 Months | Current |
Charges & borrowings
Open charges
₹13.8 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Apr 2022 | 100567629 | Hdfc Bank Limited | ₹13.8 Cr | Open |
To see the full charge records of Gromax Therapeutics Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Gromax Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Gromax Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Gromax Therapeutics has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAHCG3202G1ZE | Bihar | Active | 14 Feb 2019 |
To see the full GST registrations and return filing status of Gromax Therapeutics Private Limited, buy the company report.
Recent activity
Gromax Therapeutics Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Namita Devi Chirania ceased to be Director on 31 Mar 2021.
Charges
A charge with Hdfc Bank Limited of Rs. 1,380.00 Lakh registered on 28 Apr 2022 with Charge ID 100567629 was modified on 20 Sep 2025.
AGM
Gromax Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Gromax Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1,380.00 Lakh with Charge ID 100567629 was registered on 28 Apr 2022.
Ceased
Namita Devi Chirania ceased to be Director.
Appointed
Satanand Vaibhaw was appointed as Director.
Appointed
Aman Chirania was appointed as Director.
Incorporation
15 May 2018
Gromax Therapeutics Private Limited was registered on 15 May 2018 with Roc Mumbai & aged 8 years 5 months as per MCA records.
Frequently asked questions
Gromax Therapeutics is an active private limited company based in Mumbai, Maharashtra, India. The company works in electronic appliances retail and distribution, within the consumer electronics and durables industry. It was incorporated on 15 May 2018 (8+ years old) and is registered under CIN U47211MH2018PTC309426.
Gromax Therapeutics has 2 current directors:
- Aman Chirania - Director
- Satanand Vaibhaw - Director
The latest financial statements of Gromax Therapeutics on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Gromax Therapeutics is 10AAHCG3202G1ZE, registered in Bihar.
The CIN (Corporate Identification Number) of Gromax Therapeutics is U47211MH2018PTC309426. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gromax Therapeutics was incorporated on 15 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Namita Devi Chirania ceased to be Director on 31 Mar 2021. Satanand Vaibhaw was appointed as Director on 31 Mar 2021. Aman Chirania was appointed as Director on 15 May 2018.
Yes, Gromax Therapeutics is registered as a small enterprise under Udyam registration (number: UDYAM-MH-19-0130223).
The registered office of Gromax Therapeutics is at B – 205206 Dhanashree Heights Next To Axis Bank Veeradesai Road Andheri West Mumbai, Maharashtra, India – 400053.
Gromax Therapeutics operates in the consumer electronics and durables industry, in the electronic appliances retail and distribution segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages